Wetter Pharma-Fertigung GmbH & Co KG (manufacturing of medicinal product, primary packaging, secondary packaging, quality control of medicinal product)

Ukraine

All drugs from this manufacturer

  • ADJOVI™

    The drug is intended for the prevention of migraine in adults who experience headache attacks at least 4 days per month.

    Dosage form: solution for injection

    Active substance Dosage
    fremanezumab 225 mg/1.5 ml

    ATC: N02CD03